PharmaShots | Incisive News in 3 Shots

Subscribe Now

First Patients Dosing

Linnaeus Reports First Patients Dosing with LNS8801 + Keytruda (pembrolizumab) in P-I/II Study for Advanced Cancer

Linnaeus Reports First Patients Dosing with LNS8801 + Keytruda (pembrolizumab) in P-I/II Study for Advanced Cancer

October 14, 2020

Galapagos Reports First Patients Dosing with GLPG3970 (Toledo Compound) for Psoriasis

Galapagos Reports First Patients Dosing with GLPG3970 (Toledo Compound) for Psoriasis

September 30, 2020

Regenxbio Reports First Patients Dosing in its P-II AAVIATE Study of RGX-314 for Wet AMD

Regenxbio Reports First Patients Dosing in its P-II AAVIATE Study of RGX-314 for Wet AMD

September 9, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us